Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Jun 30, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0000899243-20-018024.pdf
0000899243-20-018024.rtf
0000899243-20-018024.xls
Jun 23, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0000899243-20-017498.pdf
0000899243-20-017498.rtf
0000899243-20-017498.xls
Jun 18, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-037764.pdf
0001209191-20-037764.rtf
0001209191-20-037764.xls
Jun 18, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-037765.pdf
0001209191-20-037765.rtf
0001209191-20-037765.xls
Jun 09, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0000899243-20-015779.pdf
0000899243-20-015779.rtf
0000899243-20-015779.xls
Jun 08, 2020 8-K Report of unscheduled material events or corporate event View HTML
0001714899-20-000060.pdf
0001714899-20-000060.rtf
0001714899-20-000060.xls
Jun 05, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-034766.pdf
0001209191-20-034766.rtf
0001209191-20-034766.xls
Jun 05, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-034768.pdf
0001209191-20-034768.rtf
0001209191-20-034768.xls
Jun 05, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-034770.pdf
0001209191-20-034770.rtf
0001209191-20-034770.xls
Jun 05, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-034765.pdf
0001209191-20-034765.rtf
0001209191-20-034765.xls
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 45
  • Page 46
  • Current page 47
  • Page 48
  • Page 49
  • …
  • Next page ›
  • Last page »
Displaying 461 - 470 of 696 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2025 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use